KYMR
Kymera Therapeutics Inc Earnings
$58.62
Earnings Summary
Revenue | $2.76Mn |
Net Profits | $-82.18Mn |
Net Profit Margins | -2973.05% |
Kymera Therapeutics Inc’s revenue fell -26.12% since last year same period to $2.76Mn in the Q3 2025. On a quarterly growth basis, Kymera Therapeutics Inc has generated -75.91% fall in its revenue since last 3-months.
Kymera Therapeutics Inc’s net profit fell -31.51% since last year same period to $-82.18Mn in the Q3 2025. On a quarterly growth basis, Kymera Therapeutics Inc has generated -7.26% fall in its net profits since last 3-months.
Kymera Therapeutics Inc’s net profit margin fell -77.99% since last year same period to -2973.05% in the Q3 2025. On a quarterly growth basis, Kymera Therapeutics Inc has generated -345.33% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.86 |
EPS Estimate Current Year | -0.86 |
Kymera Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.86 - a -3.77% fall from last quarter’s estimates.
Kymera Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.86.
Key Ratios
Earning Per Share (EPS) | -0.95 |
Kymera Therapeutics Inc’s earning per share (EPS) fell -63.79% since last year same period to -0.95 in the Q2 2025. This indicates that the Kymera Therapeutics Inc has generated -63.79% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-08-11 | -0.83 | -0.95 | -14.46% |
2025-05-09 | -0.73 | -0.82 | -12.33% |
